Foresite Capital

General contacts

Investor type

Founded

2011

AUM

$3 500 M

Location

San Francisco, California, United States

Investment Ticket

$10-50 m

Investment Stage

Series B Series A Seed Late Stage (Series C+)

Region of investment

North America Europe

Investor profile last updated: 16 August, 2026

Profile

Foresite Capital is a venture capital firm based in the United States, focusing on investing in healthcare and life sciences companies. Founded by Jim Tananbaum, the firm brings together experts with a mix of healthcare research and financial analysis experience, highlighted by team members such as Richard Lau, who has over 10 years in healthcare research, and Susan Gatrill with extensive experience in venture capital accounting.

The firm specializes in the healthcare sector, with investments spanning biotechnology, specialty pharmaceuticals, diagnostics, and medical devices. The check sizes typically range from $10-50 million, and they invest primarily in North America. While the exact AUM is not specified, Foresite Capital has managed several investment funds over its operational history.

Notable investments made by Foresite Capital include companies like Intarcia - developing continuous drug delivery technologies, 23andMe - a provider of direct-to-consumer genetic testing, Aledade - supporting primary care doctors, and Innovaccer - a healthcare data activation platform. These investments reflect their strong emphasis on high-growth healthcare companies.

Industry

Biotechnology Healthcare Services Medical Devices Other Pharmaceuticals HealthTech Software MedTech Technology Life Sciences Infrastructure Food and Beverage Foodtech

Foresite Capital Funds

Name	Type	Industry	Stage	Region	Size	AUM	Launch date
Foresite Capital Fund III, L.P	Venture Capital (VC)	Healthcare Services Life Sciences	Seed Series A Series B	North America South America Europe Middle East Africa Asia Australia and others	$5-10 m	$450 M	July 2015
Foresite Capital Fund IV, L.P	Venture Capital (VC)	Healthcare Services Life Sciences	Seed Series A Series B	North America South America Europe Middle East Africa Asia Australia and others	$5-10 m	$668 M	May 2018
Foresite Capital Opportunity Fund V, L.P.	Venture Capital (VC)	Healthcare Services Life Sciences	Seed Series A Series B	North America South America Europe Middle East Africa Asia Australia and others	$5-10 m	$186 M	February 2021
Foresite Capital Fund VI, L.P	Venture Capital (VC)	Healthcare Services Life Sciences	Seed Series A Series B	North America South America Europe Middle East Africa Asia Australia and others	$5-10 m	$900 M	June 2024
Foresite Labs Fund	Fund of funds	Biotechnology Healthcare Services Medical Devices Life Sciences Infrastructure	Seed Series A Series B	North America	$5-10 m	$173 M	March 2022
Foresite Capital Fund V, L.P	Fund of funds	Food and Beverage Foodtech Technology Life Sciences Infrastructure HealthTech	Seed Series A Series B	North America	$5-10 m	$783 M	February 2021

Contacts

Name

Title

Social Networks

Cynthia Carpenter Executive Associate to CEO and Founder, Jim Tananbaum

Executive Associate to CEO and Founder, Jim Tananbaum

c•••@•••

Richard Lau, CFA Partner

Partner

r•••@•••

Upgrade to see contacts

W7Xi2fTdzHcDMqUE W7Xi2fTdzHcDMqUE

W7Xi2fTdzHcDMqUE

[email protected]

W7Xi2fTdzHcDMqUE W7Xi2fTdzHcDMqUE

W7Xi2fTdzHcDMqUE

[email protected]

W7Xi2fTdzHcDMqUE W7Xi2fTdzHcDMqUE

W7Xi2fTdzHcDMqUE

[email protected]

Investment-team contacts for Foresite Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.

Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Foresite Capital

Is Foresite Capital a venture capital or private equity firm?

Foresite Capital is a venture capital firm. It backs companies at Series B, Series A, Seed and Late Stage (Series C+), writing tickets of $10-50 m.

Where is Foresite Capital located?

Foresite Capital is located in San Francisco, California, United States.

When was Foresite Capital founded?

Foresite Capital was founded in 2011.

What sectors and industries does Foresite Capital invest in?

Foresite Capital invests in companies and startups in Biotechnology, Healthcare Services, Medical Devices, Other, Pharmaceuticals, HealthTech, Software, MedTech, Technology, Life Sciences, Infrastructure, Food and Beverage, Foodtech.

What is Foresite Capital geographical focus of investments?

Foresite Capital invests in companies and startups in North America, Europe.

At what stages of companies and startups does Foresite Capital typically invest in?

Foresite Capital invests in companies and startups at Series B, Series A, Seed, Late Stage (Series C+).

What is the usual amount of Foresite Capital investment?

Foresite Capital usually invests $10-50 m on average.

What is the amount of assets of under management (AUM) for Foresite Capital?

Foresite Capital has around $3 500m assets under management.

When was Foresite Capital last fund created?

Foresite Capital last fund was created/launched in 2024-06-12

What are the contacts of Foresite Capital?

Foresite Capital can be reached through its website foresitecapital.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Foresite Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

Can I access Foresite Capital data via API or MCP?

Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Foresite Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.

When was the Foresite Capital profile last updated?

Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.